Neoplasm Metastasis

"Neoplasm Metastasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Descriptor ID	D009362
MeSH Number(s)	C04.697.650 C23.550.727.650
Concept/Terms	Neoplasm Metastasis Neoplasm Metastasis Metastases, Neoplasm Neoplasm Metastases Metastasis Metastases Metastasis, Neoplasm

Below are MeSH descriptors whose meaning is more general than "Neoplasm Metastasis".

Diseases [C]
Neoplasms [C04]
Neoplastic Processes [C04.697]
Neoplasm Metastasis [C04.697.650]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Neoplastic Processes [C23.550.727]
Neoplasm Metastasis [C23.550.727.650]

Below are MeSH descriptors whose meaning is related to "Neoplasm Metastasis".

Below are MeSH descriptors whose meaning is more specific than "Neoplasm Metastasis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasm Metastasis" by people in this website by year, and whether "Neoplasm Metastasis" was a major or minor topic of these publications.

Bar chart showing 153 publications over 28 distinct years, with a maximum of 14 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	1	1	2
1998	0	1	1
1999	0	1	1
2000	0	1	1
2001	2	1	3
2002	0	2	2
2003	1	2	3
2004	2	5	7
2005	1	4	5
2006	0	6	6
2007	2	6	8
2008	3	5	8
2009	1	6	7
2010	1	4	5
2011	1	10	11
2012	1	8	9
2013	0	4	4
2014	1	5	6
2015	2	12	14
2016	0	5	5
2017	0	5	5
2018	0	6	6
2019	2	5	7
2020	0	11	11
2021	1	6	7
2024	0	4	4
2025	0	4	4

Below are the most recent publications written about "Neoplasm Metastasis" by people in Profiles.

Candelieri-Surette D, Lee J, Lynch JA, Chang NN, Nelson TJ, Teerlink CC, Pimentel C, Schoen MW, Berlowitz D. Epidemiology of Metastatic Castration-Resistant Prostate Cancer in Veterans Nationwide. J Natl Compr Canc Netw. 2025 Jul 14; 23(8):307-313.

View in: PubMed
Roy R, Schunkert EM, Olivova P, Gilar M, Geromanos S, Li GZ, Gebler J, Dagher A, El-Hayek A, Aldakhlallah R, Staffa SJ, Zurakowski D, Lotz M, Pories S, Moses MA. Identification of vitronectin as a potential non-invasive biomarker of metastatic breast cancer using a label-free LC-MS/MS approach. Breast Cancer Res. 2025 May 29; 27(1):94.

View in: PubMed
Weissenrieder JS, Peura J, Paudel U, Bhalerao N, Weinmann N, Johnson C, Wengyn M, Drager R, Furth EE, Simin K, Ruscetti M, Stanger BZ, Rustgi AK, Pitarresi JR, Foskett JK. Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Rep. 2025 May 27; 44(5):115627.

View in: PubMed
Lee N, Kim D. Adapt or Perish: Efficient Selenocysteine Insertion Is Critical for Metastasizing Cancer Cells. Cancer Res. 2025 Feb 01; 85(3):410-412.

View in: PubMed
He SQ, Liu GY, Yu YH, Wang L, Zhang GY, Peng DS, Bei WX, Chen CL, Lv SH, Zhao ZY, Huang Y, Xiang YQ. Efficacy of local-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy: A multicenter, propensity score matching study. Radiother Oncol. 2025 Feb; 203:110687.

View in: PubMed
Avelino ARM, Pulipati S, Jamouss K, Bhardwaj PV. Updates in Treatment of HER2-positive Metastatic Breast Cancer. Curr Treat Options Oncol. 2024 Dec; 25(12):1471-1481.

View in: PubMed
Rozen EJ, Frantz W, Wigglesworth K, Vessella T, Zhou HS, Shohet JM. Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. Mol Cancer Ther. 2024 Aug 01; 23(8):1124-1138.

View in: PubMed
Liu GY, Ye YF, Jiang YF, Chen GJ, Xia WX, Huang YS, Gao TS, Liu YM, Hou YT, Li JF, Liu JH, Lu N, Chen CL, Ke LR, Liang H, Bei WX, Li WZ, Dong SH, Liu Q, Xie C, Yao HR, Xiang YQ. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial. BMJ. 2024 06 19; 385:e077890.

View in: PubMed
Cornelius P, Mayes BA, Petersen JS, Turnquist DJ, Dufour PJ, Dannenberg AJ, Shanahan JM, Carver BJ. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity. Mol Cancer Ther. 2024 May 02; 23(5):595-605.

View in: PubMed
Basso U, Procopio G, Fornarini G, Massari F, Bearz A, Fratino L, Milella M, Bassanelli M, Ermacora P, Bimbatti D, Verzoni E, Rizzo M, Porta C. Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16). Oncology. 2021; 99(12):747-755.

View in: PubMed

People

Explore

Similar Concepts

Top Journals